A Study of Postural Tachycardia Syndrome

Overview

Información sobre este estudio

The purpose of this research study is to better understand what causes POTS. We believe that a number of different causes of POTS exist and that detailed testing can demonstrate the different causes. Knowing what causes POTS in a particular patient will be helpful in choosing the right treatment strategy for that particular patient in the future.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria

POTS:

  • Males or females age 18-50 years.
  • Orthostatic HR increment of ≥30bpm to an absolute orthostatic HR ≥120bpm within 10 min of head-up tilt.
  • Frequent orthostatic symptoms (lightheadedness, faintness), that resolve promptly with recumbency

Control Subjects:

  • Males or females age 18-50 years, age and gender matched to patients
  • Normal Autonomic Reflex Screen, normal Autonomic Symptom Profile

Subjects Undergoing Skin Biopsy and Autonomic Reflex Screen Only

  • Males or females age 18-80 years

Exclusion Criteria

POTS and Controls

  • Orthostatic hypotension (decrease of systolic BP≥30mmHg and/or diastolic BP≥15mmHg within 3min of tilt)
  • Pregnant/lactating females – a pregnancy test will be required for women of childbearing potential.
  • The presence of failure of other organ systems or systemic illness that can affect autonomic function.
  • Concomitant therapy with anticholinergic, alpha-/beta-adrenergic antagonists or other medication which could interfere with autonomic testing. Potentially interfering medication will be held for five half-lives.

Subjects Only Undergoing Skin Biopsy and Autonomic Reflex Screen Only

  • Pregnant/lactating females – a pregnancy test will be required for women of childbearing potential.
  • The presence of failure of other organ systems or systemic illness that can affect autonomic function.
  • Concomitant therapy with anticholinergic, alpha-/beta-adrenergic antagonists or other medication which could interfere with autonomic testing. Potentially interfering medication will be held for five half-lives.

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus

Rochester, Minn.

Investigador principal de Mayo Clinic

Wolfgang Singer, M.D.

Cerrado para la inscripción

More information

Publicaciones

Publications are currently not available
.
CLS-20312406

Mayo Clinic Footer